Oncology Research and Treatment

Aims & Scope

Oncology Research and Treatment offers an interdisciplinary forum for cancer research and treatment.

Peer-reviewed original and review articles cover a wide range of aspects in medical hematology and oncology, surgical, neurosurgical, gynecological, pediatric and urological oncology, oral and maxillofacial surgery, dermatological oncology, diagnostics, radiation oncology, psychological care, pathology, clinical-translational oncology, biometry, and oncological rehabilitation.

Continuous medical education and clinical news form a further focus.

Compact and current, Oncology Research and Treatment keeps both clinicians and researchers up to date.

Oncology Research and Treatment is addressed to clinicians and practitioners working and researching in the field of hematology and oncology.

Please note that the focus of Oncology Research and Treatment is to report clinical and translational research.

Basic research is not in the scope of the journal.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.6
2024	2.00

SJR (SCImago Journal Rank)

Year	Value
2024	0.589

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	58

Journal Rank

Year	Value
2024	9858

Journal Citation Indicator

Year	Value
2024	328

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Liquid Biopsy: Current Status and Future Perspectives

  Citation: 194

  Authors: Sonja, Klaus

• Anti-Angiogenics: Current Situation and Future Perspectives

  Citation: 178

  Authors: Katja, Justus

• Warburg Effect or Reverse Warburg Effect? A Review of Cancer Metabolism

  Citation: 161

  Authors: Xiao Dong, Shi Xiu, Hai Ping, Yan Wei, Yong Hua, Xue Cheng, You Lin, Xin Sheng, Hai Tao

• Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer

  Citation: 160

  Authors: R.-D., S.-E., F., G., D., C., P., U., A., H., G.

• Fatigue in the General Population

  Citation: 151

  Authors: R., O., A.

• PD-1/PD-L1 Pathway in Breast Cancer

  Citation: 149

  Authors: Florian, Stefan, Luisa, Alexandra, Christoph, Christof

• The Ras-Raf-MEK-ERK Pathway in the Treatment of Cancer

  Citation: 119

  Authors: R.A., M.E., D.

• Epidemiology and Molecular Biology of Head and Neck Cancer

  Citation: 118

  Authors: Adriana, Jochen

• Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast Cancer

  Citation: 95

  Authors: N., U.R., K., L, D.K.

• Immune Thrombocytopenia - Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTI

  Citation: 94

  Authors: Axel, Oliver, Helmut, Volker, Wolfgang, Thomas, Ingrid, Matthias

---